By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



22 Rue Garnier

Neuilly Sur Seine    92200  France
Phone: N/A Fax:




Company News
Galapagos (GLPG.BR) Initiates Phase 1 First-In-Human Study With GLPG1972, Receives €3.5 Million Milestone From Servier 11/20/2015 9:00:53 AM
Servier Exercises Exclusive Worldwide Licensing Option With Cellectis (ALCLS) For UCART19, An Allogeneic CAR-T Cell Therapy For Hematological Malignancies 11/19/2015 11:58:48 AM
Pfizer (PFE), Servier Snap Up Right to Cellectis (ALCLS)' Blood Cancer Therapy in $338 Million+ Deal 11/19/2015 5:57:59 AM
Servier Walks Away from a $450 Million Cancer Deal with MacroGenics, Inc. (MGNX) 10/29/2015 7:33:23 AM
VECT-HORUS Announces The Signing Of A Scientific Collaboration Agreement With Servier 6/19/2015 10:26:57 AM
Servier, Taiho Pharma Strike $130 Million+ Cancer Pact 6/15/2015 6:15:11 AM
Servier Initiates Phase 2 Study Of Gevokizumab In Patients With Diabetic Nephropathy 4/1/2015 6:39:56 AM
Novo Nordisk A/S (NVO),Takeda (TKPYY), Servier, Celgene (CELG) Among Top Sponsors Rated By Investigative Sites In New CenterWatch Inc. Survey 3/2/2015 11:03:25 AM
ARMGO Pharma Inc. And Servier Announce Advancement Of Rycal ARM210/S48168 Into Clinical Stage Program Targeting Duchenne Muscular Dystrophy 12/4/2014 12:11:41 PM
GeNeuro, Servier Ink $455M MS Drug Pact 12/2/2014 6:47:52 AM